α-Smooth muscle actin-positive myofibroblasts in endometrial stroma are not a reliable criterion for the diagnosis of well differentiated endometrioid adenocarcinoma in small tissue samples

International Journal of Gynecological Pathology

Volumn 20, Issue 3, 2001, Pages 232-238

  Czernobilsky, Bernard ^a,e   Gabbiani, Giulio ^b   Prus, Diana ^c   Lifschitz Mercer, Beatriz ^d  

^a LEM Pathology Laboratory   (Israel)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^e Patho Lab Laboratories   (Israel)

Author keywords

Desmoplastic reaction; Endometrioid carcinoma; SM actin positive myofibroblasts

Indexed keywords

ALPHA ACTIN;

ADENOCARCINOMA; CELL DIFFERENTIATION; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENDOMETRIOID CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MYOFIBROBLAST; PRIORITY JOURNAL; STROMA; TISSUE SLICE;

EID: 0034984507     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-200107000-00005     Document Type: Conference Paper

References (31)

1. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well differentiated carcinoma
2. Endometrial hyperplasia and carcinoma: Diagnostic considerations
3. Endometrium
4. The identification of stromal invasion in the distinction of atypical endometrial hyperplasia from well differentiated adenocarcinoma
5. Tumors of the uterine corpus and gestational trophoblastic diseases
6. Endometrial hyperplasia and related cellular changes
7. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma
8. Toward the development of morphologic criteria for well-differentiated adenocarcinoma of the endometrium
9. Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma: A diagnostic test for myoinvasion
10. Endometrial hyperplasia, metaplasia and carcinoma
11. A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens
12. Myofibroblasts in the stroma of invasive and metastatic carcinoma: A possible host response to neoplasia
13. A monoclonal antibody against alpha-smooth muscle actin: A new probe for smooth muscle cell differentiation
14. Correlation between the distribution of smooth muscle or nonmuscle myosins and alpha-smooth muscle actin in normal and pathological soft tissues
15. Mechanisms of myofibroblast activity and phenotypic modulation
16. The myofibroblast: Biologic, pathologic and theoretical considerations
17. Myofibroblast
18. Phenotypic features of stromal cells in normal, premalignant and malignant conditions
19. Alpha-Smooth muscle actin (alpha-SM actin) in normal human ovaries, in ovarian stromal hyperplasia and in ovarian neoplasms
20. Human smooth muscle autoantibody: Its identification as antiactin autoantibody and a study of its binding to "nonmuscular" cells
21. Alpha-smooth muscle actin and other stromal markers in endometrial mucosa
22. Expression of alpha-smooth-muscle actin in stromal cells of the uterine cervix during epithelial neoplastic changes
23. Normal histology of the uterus and fallopian tube
24. The biology of the myofibroblast: Relationship to wound contraction and fibrocontractive disease
25. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins
26. Atypical polypoid adenomyofibroma (APA) versus well-differentiated endometrial carcinoma with prominent stromal matrix: An immunohistochemical study
27. Effect of gamma-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: An open pilot study
28. Cellular biology of Dupuytren's disease
29. Morphological and immunohistochemical differences between keloid and hypertrophic scar
30. Effect of endothelin-I on alpha-smooth muscle actin expression and on alveolar fibroblasts proliferation in interstitial lung disease
31. Endometrial neoplasia: Retrogressive terminology